Face Swelling: What Could Be Causing It

Allergic and Immune-Mediated Causes

Histamine-driven allergic reactions are the most common reason for sudden facial swelling. The swelling appears within minutes of exposure to a food allergen, insect sting, or medication and typically involves the lips, eyelids, and periorbital tissue.

Acute urticaria with angioedema affects an estimated 15% to 20% of the general population at some point during their lifetime, according to a 2014 review in the Journal of Allergy and Clinical Immunology [1]. The mechanism involves mast cell degranulation and release of histamine, leukotrienes, and prostaglandins into the dermis and subcutaneous tissue. Swelling can be asymmetric. It may favor one eyelid or one side of the lip while sparing the other.

Anaphylaxis represents the severe end of this spectrum. The European Academy of Allergy and Clinical Immunology (EAACI) 2021 guidelines define anaphylaxis as a serious systemic reaction that is rapid in onset and may cause death [3]. Facial swelling with concurrent hypotension, bronchospasm, or gastrointestinal symptoms requires immediate intramuscular epinephrine (0.3 to 0.5 mg of 1:1,000 solution in adults). Delay in epinephrine administration beyond 30 minutes is associated with increased fatality risk.

A separate, non-histaminergic pathway causes angioedema through bradykinin accumulation. This form does not respond to antihistamines or epinephrine. It occurs in hereditary angioedema (HAE), a condition caused by C1-esterase inhibitor deficiency affecting approximately 1 in 50,000 people [4]. HAE attacks last 2 to 5 days without treatment. Icatibant (a bradykinin B2 receptor antagonist) or C1-inhibitor concentrate can shorten attack duration to under 24 hours in most patients.

Drug-Induced Facial Swelling

Medications cause facial edema through several distinct mechanisms, and the offending agent is not always obvious.

ACE inhibitors are the best-studied culprit. A 2012 meta-analysis published in the Annals of Internal Medicine found angioedema incidence of 0.30% with ACE inhibitors versus 0.07% with placebo [2]. The risk is three to four times higher in Black patients compared to white patients. Onset can occur within days of starting the drug or, more insidiously, after years of uneventful use. The mechanism involves bradykinin accumulation because ACE normally degrades bradykinin. Switching to an angiotensin receptor blocker (ARB) carries a low cross-reactivity risk of approximately 2% to 8%.

Corticosteroids cause a different pattern. Chronic use (prednisone >7.5 mg daily for more than 3 weeks, or equivalent) promotes centripetal fat redistribution, producing the characteristic "moon facies" of iatrogenic Cushing syndrome [5]. This is not true edema but adipose tissue deposition.

Other common drug causes include:

• Amlodipine and other dihydropyridine calcium channel blockers: peripheral and facial edema in 5% to 10% of users, dose-dependent
• Pioglitazone and rosiglitazone: fluid retention affecting up to 15% of patients at higher doses
• NSAIDs: can trigger angioedema through cyclooxygenase-1 inhibition and shunting of arachidonic acid toward the leukotriene pathway
• Gabapentin and pregabalin: peripheral edema in 2% to 8% of users, occasionally involving the face

Infectious Causes

Facial cellulitis, periorbital cellulitis, dental abscesses, and salivary gland infections produce swelling that is typically unilateral, painful, warm, and progressive over hours to days.

Odontogenic infections account for a significant proportion of facial swelling presentations. A 2019 study in the British Journal of Oral and Maxillofacial Surgery reported that dental infections were the primary cause in 49% of patients presenting with acute facial swelling requiring hospital admission [6]. The infection spreads from the tooth apex through fascial planes, potentially reaching the submandibular, sublingual, or parapharyngeal spaces. Ludwig angina, a bilateral submandibular space infection, is a true emergency. It can obstruct the airway within hours.

Periorbital (preseptal) cellulitis presents as unilateral eyelid swelling, erythema, and tenderness. It most commonly follows sinusitis, insect bites, or minor skin trauma. The key clinical distinction is between preseptal and orbital cellulitis. Orbital cellulitis involves proptosis, pain with eye movement, and vision changes. It requires IV antibiotics and often surgical drainage. CT imaging with contrast is the standard for differentiating these two entities [7].

Parotitis and submandibular sialadenitis cause swelling over the involved gland. Bacterial parotitis typically produces purulent discharge from the Stensen duct. Viral parotitis (mumps) causes bilateral swelling, though onset may be asymmetric.

Herpes zoster (shingles) of the trigeminal nerve can produce significant facial edema along a dermatomal distribution. This is often preceded by pain and followed by the characteristic vesicular eruption.

Endocrine and Metabolic Causes

Several hormonal conditions produce characteristic facial swelling patterns that develop gradually and may go unrecognized for months.

Hypothyroidism causes facial puffiness through accumulation of glycosaminoglycans (primarily hyaluronic acid) in the dermis. This produces the "myxedematous" facies: puffy eyelids, swollen lips, a thickened tongue, and a generalized fullness of the face. The swelling is non-pitting because it is not simple fluid but rather a gel-like mucopolysaccharide infiltrate [8]. The 2012 American Thyroid Association guidelines note that overt hypothyroidism affects 0.3% to 3.7% of the U.S. adult population, and subclinical hypothyroidism affects an additional 4% to 10% [9]. A TSH level above 10 mIU/L with low free T4 confirms the diagnosis. Levothyroxine replacement at 1.6 mcg/kg/day typically resolves facial myxedema over 3 to 6 months.

Cushing syndrome, whether endogenous (pituitary adenoma, adrenal tumor, ectopic ACTH) or exogenous (chronic glucocorticoid therapy), produces progressive facial rounding. Fat accumulates in the cheeks, temporal fossae, and supraclavicular pads. A 24-hour urinary free cortisol level exceeding three times the upper limit of normal, or a positive overnight dexamethasone suppression test (1 mg at 11 PM, cortisol >1.8 mcg/dL at 8 AM), supports the diagnosis [5].

Nephrotic syndrome causes generalized edema that is often most noticeable in the face upon waking, particularly around the eyes. Proteinuria exceeding 3.5 g per 24 hours leads to hypoalbuminemia and reduced plasma oncotic pressure. The periorbital tissue is loose and distensible, making it an early site for fluid accumulation. A spot urine protein-to-creatinine ratio >3.5 g/g and serum albumin <3.0 g/dL are diagnostic [10].

Premenstrual fluid retention affects up to 92% of menstruating women to some degree, according to a 2019 systematic review in the Journal of Women's Health [11]. Progesterone-mediated aldosterone activation promotes sodium and water retention in the luteal phase. Facial puffiness is common but self-limited, resolving within 1 to 2 days of menstruation onset.

Superior Vena Cava Syndrome and Venous Obstruction

Obstruction of venous drainage from the head and neck produces bilateral facial and periorbital edema, often with a violaceous discoloration and distended neck veins. This pattern is distinct from all other causes and requires urgent investigation.

Superior vena cava (SVC) syndrome is caused by malignancy in approximately 60% to 85% of cases, with lung cancer and lymphoma being the most frequent culprits [12]. Thrombosis related to central venous catheters and pacemaker leads accounts for most of the remaining cases. Symptoms worsen when the patient bends forward or lies flat. CT angiography of the chest confirms the diagnosis and identifies the underlying cause.

"SVC syndrome presenting with isolated facial edema and no other symptoms is uncommon but documented. Clinicians should maintain a high index of suspicion in any patient with progressive, painless, bilateral facial swelling and known cancer or an indwelling central venous catheter," as stated in Harrison's Principles of Internal Medicine, 21st edition [13].

Treatment depends on the underlying cause. Malignant SVC syndrome may respond to radiation, chemotherapy, or endovascular stenting. Thrombotic SVC syndrome requires anticoagulation and potentially catheter-directed thrombolysis.

Autoimmune and Inflammatory Conditions

Systemic lupus erythematosus (SLE) can cause facial swelling through multiple mechanisms: the malar ("butterfly") rash itself involves dermal inflammation and edema, lupus nephritis can produce nephrotic-range proteinuria, and lupus-associated angioedema occurs in approximately 7% to 10% of SLE patients [14]. Anti-C1q antibodies, found in some lupus patients, may contribute to the angioedema phenotype.

Dermatomyositis produces a heliotrope rash with periorbital edema as a hallmark feature. The violaceous discoloration of the upper eyelids with accompanying swelling is highly specific for this condition.

Sarcoidosis can cause bilateral parotid gland enlargement (Heerfordt syndrome when accompanied by uveitis, facial palsy, and fever). The parotid swelling is firm and non-tender.

Contact dermatitis of the face, while technically an immune-mediated reaction, deserves separate mention because it is extremely common. Hair dyes containing paraphenylenediamine, cosmetics, fragrances, and preservatives can produce dramatic facial edema. The face swells disproportionately because the skin is thin and vascular. Patch testing identifies the specific allergen.

Diagnostic Approach

The clinical history and physical examination narrow the differential efficiently in most cases. Three questions matter most: how quickly did the swelling develop, is it unilateral or bilateral, and is it painful?

"The tempo of onset is the single most useful diagnostic clue in facial swelling," according to a 2020 review in Emergency Medicine Clinics of North America [15]. Hyperacute onset (minutes) suggests anaphylaxis or angioedema. Acute onset (hours to days) points to infection or allergic reaction. Subacute to chronic onset (weeks to months) raises concern for endocrine disease, malignancy, or autoimmune conditions.

Initial laboratory evaluation for unexplained facial swelling typically includes:

• Complete blood count with differential: eosinophilia suggests allergy or parasitic infection
• Comprehensive metabolic panel: creatinine and albumin assess renal function
• TSH and free T4: screen for hypothyroidism
• Urinalysis with protein quantification: detect nephrotic syndrome
• Tryptase level (if drawn within 1 to 4 hours of acute onset): confirms mast cell activation
• C4 level: screening test for hereditary angioedema (C4 is low even between attacks in 95% of HAE patients) [4]
• C1-esterase inhibitor level and function: confirmatory for HAE if C4 is low

Imaging depends on the clinical scenario. CT with contrast is indicated for suspected orbital cellulitis, deep space neck infections, or SVC syndrome. Ultrasound is useful for evaluating salivary gland pathology. MRI may be needed for orbital or intracranial processes.

Treatment by Cause

Treatment varies dramatically depending on the underlying etiology, and misidentifying the cause can lead to ineffective or dangerous therapy.

For histamine-mediated angioedema and urticaria, second-generation H1 antihistamines (cetirizine 10 mg, loratadine 10 mg, or fexofenadine 180 mg daily) are first-line. The EAACI/GA2LEN guidelines recommend up-dosing to four times the standard dose before adding omalizumab (anti-IgE monoclonal antibody, 300 mg subcutaneously every 4 weeks) for chronic cases [1]. Systemic corticosteroids (prednisone 40 to 60 mg for 3 to 5 days) are reserved for severe acute episodes.

For bradykinin-mediated angioedema (HAE or ACE inhibitor-induced), antihistamines and corticosteroids are ineffective. HAE attacks respond to on-demand treatment with icatibant (30 mg subcutaneously), C1-inhibitor concentrate (20 IU/kg IV), or ecallantide (30 mg subcutaneously) [4]. Long-term prophylaxis options include lanadelumab (a monoclonal antibody against kallikrein, 300 mg subcutaneously every 2 weeks), oral berotralstat (150 mg daily), and subcutaneous C1-inhibitor (60 IU/kg twice weekly). For ACE inhibitor angioedema, the drug must be permanently discontinued.

Infectious causes require targeted antimicrobial therapy. Facial cellulitis typically requires coverage for Staphylococcus aureus and Streptococcus pyogenes (amoxicillin-clavulanate 875/125 mg twice daily, or clindamycin 300 mg three times daily if penicillin-allergic). Odontogenic infections may need surgical drainage in addition to antibiotics. Periorbital cellulitis in children warrants close monitoring and often IV antibiotics to prevent progression to orbital involvement [7].

Hypothyroid myxedema resolves with thyroid hormone replacement. Most patients receive levothyroxine, starting at 25 to 50 mcg daily in older adults or those with cardiac disease, and 1.6 mcg/kg/day in younger, healthy patients [9]. The TSH should be rechecked at 6 to 8 weeks with dose adjustments in 12.5 to 25 mcg increments.

Nephrotic syndrome management targets the underlying glomerular disease (minimal change disease, membranous nephropathy, focal segmental glomerulosclerosis) and includes sodium restriction (<2 g/day), loop diuretics for symptomatic edema, and ACE inhibitors or ARBs to reduce proteinuria [10].

When Facial Swelling Is an Emergency

Certain presentations require activation of emergency medical services without delay.

Anaphylaxis with facial swelling, difficulty breathing, stridor, or hemodynamic instability demands intramuscular epinephrine as the first intervention. Data from the UK National Audit of Anaphylaxis show that the median time from allergen exposure to cardiac arrest is 5 minutes for iatrogenic triggers, 15 minutes for insect venom, and 30 minutes for food [3]. Every minute of delay matters.

Ludwig angina presents with bilateral submandibular swelling, a "woody" firm floor of the mouth, trismus, drooling, and a muffled voice. Airway compromise develops rapidly, and the mortality rate without treatment approaches 50%. Urgent CT imaging, IV antibiotics (ampicillin-sulbactam 3 g every 6 hours or clindamycin plus ceftriaxone), and possible surgical drainage or intubation are required [6].

HAE laryngeal attacks cause potentially fatal airway obstruction. All HAE patients should carry on-demand rescue therapy, and any episode involving throat tightness, voice change, or dysphagia should be treated immediately and the patient transported to an emergency department even if symptoms begin to improve [4].

Patients with new bilateral facial swelling, distended neck veins, and dyspnea need urgent CT angiography to evaluate for SVC syndrome, which may indicate an undiagnosed thoracic malignancy requiring same-day oncologic consultation [12].